CC
The Chemours CompanyNYSEBasic Materials$21.55+0.14%ClosedMarket Cap: $3.23B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
12.96
P/S
0.56
EV/EBITDA
39.50
DCF Value
$5.80
FCF Yield
1.6%
Div Yield
1.6%
Margins & Returns
Gross Margin
15.5%
Operating Margin
-0.1%
Net Margin
-6.6%
ROE
-113.2%
ROA
-5.3%
ROIC
-0.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.33B | 11.5% | $-259.0M | $-61.0M | $-0.39 | $0.09 |
| FY 2025 | $5.81B | 15.5% | $-5.0M | $-386.0M | $-2.56 | $0.51 |
| Q3 2025 | $1.50B | 15.7% | $104.0M | $60.0M | $0.40 | $0.09 |
| Q2 2025 | $1.61B | 17.2% | $72.0M | $-381.0M | $-2.54 | $0.09 |
| Q1 2025 | $1.37B | 17.3% | $78.0M | $-4.0M | $-0.03 | $0.25 |
| Q4 2024 | $1.39B | 19.6% | $75.0M | $-8.0M | $-0.05 | $0.25 |
| FY 2024 | $5.78B | 19.9% | $443.0M | $86.0M | $0.57 | $1.00 |
| Q3 2024 | $1.50B | 19.1% | $122.0M | $-27.0M | $-0.18 | $0.25 |
| Q2 2024 | $1.55B | 19.8% | $130.0M | $60.0M | $0.47 | $0.25 |
| Q1 2024 | $1.36B | 20.9% | $113.0M | $54.0M | $0.34 | $0.25 |
| Q4 2023 | $1.41B | 18.1% | $107.0M | $-18.0M | $-0.17 | $0.25 |
| FY 2023 | $6.08B | 21.5% | $-123.0M | $-238.0M | $-1.60 | $1.00 |